Century Therapeutics, Inc. SEC filings IPSC
Century Therapeutics, Inc. has 444 filings in SEC EDGAR's recent list, going back to Mar 15, 2021. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B7 | Filing | May 21, 2026 | — |
| 424B5 | Prospectus supplement | Mar 26, 2026 | — |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| S-3 | Shelf registration | Feb 5, 2026 | — |
| S-3/A | Filing | Jan 5, 2026 | — |
| S-3 | Shelf registration | Jul 10, 2025 | — |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 424B3 | Prospectus | Jun 26, 2024 | — |
| S-3 | Shelf registration | Jun 18, 2024 | — |
| 424B3 | Prospectus | May 22, 2024 | — |
| S-3 | Shelf registration | May 15, 2024 | — |
| S-8 | Employee stock plan registration | Mar 14, 2024 | — |
| S-8 | Employee stock plan registration | Mar 17, 2023 | — |
| S-3 | Shelf registration | Jul 1, 2022 | — |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| S-8 | Employee stock plan registration | Jul 2, 2021 | — |
| 424B4 | Prospectus | Jun 21, 2021 | — |
| S-1/A | Amended registration statement | Jun 15, 2021 | — |
| S-1/A | Amended registration statement | Jun 14, 2021 | — |
| S-1 | Registration statement | May 28, 2021 | — |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IPSC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Philadelphia, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1850119
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.